Scrip's Rough Guide to Immuno-Oncology

If there's one area of pharmaceutical R&D guaranteed to stay in the spotlight over the next few years it's immuno-oncology – this is one of the most promising and quickest-growing areas of cancer research, as well as one of the most active areas for licensing deals and acquisitions.

But the field is complex and fast-moving, making it tricky for a non-specialist to get a handle on it. What...